The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development process for industry and patients. Our two companies are applying AI in ...
Fractyl Health, Inc. announced that it will present preclinical data on its Rejuva gene therapy platform, which targets obesity and type 2 diabetes, at the American Society of Gene and Cell Therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results